n
a
v
Portfolio
Genetics
AmplideX® Fragile X Dx & Carrier Screen Kit
AmplideX® PCR/CE FMR1 Kit
AmplideX® mPCR FMR1 Kit
AmplideX® FMR1 Controls
Xpansion Interpreter®
AmplideX® PCR/CE C9orf72 Kit
AmplideX® PCR/CE
DMPK
Kit
AmplideX® PCR/CE
SMN1/2
Plus Kit
AmplideX® PCR/CE
HTT
Kit
Oncology
QuantideX® qPCR BCR-ABL IS Kit
QuantideX® qPCR BCR-ABL minor Kit
QuantideX® NGS RNA Lung Cancer Kit
QuantideX® NGS DNA Hotspot 21 Kit
Custom & Companion Diagnostics
Partnered R&D
CAP-Accredited CLIA Lab
CTA Testing Site
Validated Platforms & Assays
Tumor Bank
Custom Controls
SARS CoV-2 Panel
Armored Reagents
In Vitro
Transcribed RNA
Plasmid DNA
Companion Diagnostics
Enabling Technologies
Assay Chemistries
Bioinformatics
Product Development Process
Resources
Publications
Articles
Whitepapers
Posters
Disease Information
Fragile X
Leukemia
Dementia
Other Resources
Videos
Safety Data Sheets
Sales Contacts
Our Culture
Employee Spotlights
Culture & Heritage
Sales Contacts
About
Leadership Team
Culture and Heritage
Press Releases
Upcoming Events
Business Development
Contact
Careers
Search
News
Home
News
Press Releases
Year
Select Year
2020
2019
2018
2017
2016
2015
2014
2013
2012
November 8, 2017
Asuragen to Present at Upcoming 2017 Association for Molecular Pathology (AMP) Annual Meeting
Share
October 10, 2017
Asuragen to Present at 2017 American Society of Human Genetics (ASHG) Conference
Share
October 10, 2017
Asuragen CEO to Speak at 2017 World CDx Summit
Share
August 2, 2017
Asuragen Expands QuantideX® qPCR BCR-ABL Portfolio for Monitoring Molecular Response in Chronic Myeloid Leukemia
Share
April 25, 2017
Asuragen Strengthens Repetitive Sequence and Short Structural Variant Intellectual Property Portfolio
Share
March 14, 2017
Asuragen Launches the AmplideX® PCR/CE TOMM40 Kit1 Expanding Portfolio into the Alzheimer’s and Cognitive Impairment Space
Share
February 20, 2017
Asuragen and Thermo Fisher Scientific to Collaborate on Diagnostic Kits for 3500 Dx Series Genetic Analyzer
Share
November 8, 2016
Asuragen to Present at 2016 Association for Molecular Pathology Annual Meeting
Share
November 1, 2016
Asuragen Launches QuantideX® NGS RNA Lung Cancer Kit (RUO)
Share
August 9, 2016
Asuragen Develops Armored RNA Quant® Zika Virus Control
Share
Prev
1
2
3
4
5
6
7
Next
About
About
Leadership Team
Board of Directors
Culture and Heritage
Press Releases
Upcoming Events
Business Development
Back To
Top
